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Conclusions: This first-in-man experience demonstrates the ability of circumfer-
ential intravascular therapeutic ultrasound to significantly improve blood pressure
in patients with resistant hypertension. Longer term follow-up is necessary to
confirm these results.
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Background: An ageing UK population in combination with a preference for
treating acute myocardial infarction (AMI) with PPCI has lead to an increase in
the number of octogenarians treated with PPCI. The aim of the study was to
provide an insight into clinical and procedural characteristics of octogenarian
PPCI including in-hospital outcomes, mortality and a comparison between radial
and femoral PPCI strategies.
Methods: From April 2007 to August 2011, consecutive octogenarians treated with PPCI
at our institute were retrospectively included in the study cohort. Baseline characteristics,
procedural results and in-hospital outcomes were analysed. A matched pair analysis was
performed comparing 37 octogenarians with 37 patients  80 years treated with PPCI in
2010. Finally, an intra-age analysis was performed comparing outcomes between radial
and femoral PPCI procedures. All cause mortality was taken at end points of in-hospital,
30 days and 1 year.
Results: 177 octogenarians were treated with PPCI during the study period. The annual
proportion of octogenarians increased significantly to as many as 1 in 5 cases (7.0% to
20.0%, p0.05). Overall in hospital mortality was 14.7% (n26) with the highest
mortality in patients 95 years (33.3%). Compared to patients 80 years, octogenarians
had significantly longer median procedural times (58 mins vs 43 mins, p 0.05), median
discharge times (5 days vs 3 days, p  0.05) and more post procedural complications. In
comparison to femoral PPCI, radial PPCI by high volume operators was associated with
fewer vascular complications and shorter discharge times. Radial PPCI was associated
with significantly lower mortality at 1 year than femoral PPCI, 11.1% (n4) vs 28.5%
(n39) respectively (p0.05).
Conclusions: The proportion of octogenarian PPCI patients has increased. This is a high
risk population with longer procedures, more post procedural complications and longer
discharge times compared to younger patients. The study demonstrated that radial PPCI
by high volume operators resulted in fewer vascular complications, shorter discharge
times and lower mortality at 1 year compared to femoral PPCI, consistent with recently
published randomised trials.
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Background: For some diseases, different demographic subgroups may have different
prevalence, diagnosis, disease progression and treatment outcomes. Although cardiovas-
cular disease (CVD) is the number one killer for women and men, women have
historically been underrepresented in cardiovascular clinical trials (CVCTs). To accu-
rately assess sex differences in the safety and efficacy of medical devices, it is necessary
to have representation of both sexes in clinical trials to allow for sex specific analysis. The
purpose of this study was to assess the participation of women and ethnic subgroups in
CVCTs submitted in support of medical device premarket applications (PMAs) approved
by the US FDA from 2002 to 2011.
Methods: All CVCTs in approved PMAs between 2002-2011 were included in the study.
Descriptive analyses of the study participants’ ethnicity and sex were done. Demographic
data from PMAs were analyzed in 12 month intervals to detect any trends in the
participation of women and ethic subgroups.
Results: One hundred cardiovascular PMAs were approved between 2002 and 2011. One
PMA was excluded from review as it addressed a pediatric population. Women’s
participation in PMA CVCTs was: 2002 (31.1%), 2003 (35.8%), 2004 (27.9%), 2005
(36.3%), 2006 (27.1%), 2007 (38.5%), 2008 (34%), 2009 (32.8%), 2010 (26.9%) and
2011 (39.6 %). The average women’s percentage of participation in PMAs for this
10-year period was 32.9%. Twenty-one PMAs included ethnicity data with the following
average participation rates: White (85.9 %), African American (8.3%), Hispanic (2.9%),
Asian (1.3 %), Native Hawaiian (‹1%), Native American (‹1%), Other (1.3%).
Conclusions: This ten year review indicates that there is no recognizable trend and that
women’s participation in CVCTs in approved PMAs ranged from 26.9 to 39.6% over the
ten year period. There is a need to increase reporting of data by ethnicity. An increase in
the numbers of ethnic subgroups participating in CVCTs would allow for outcomes
analysis in these populations.
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Background: Octogenarians constitute an increasing proportion of patients referred for
percutaneous coronary intervention (PCI) for stable angina and acute coronary syndromes
(ACS). However, there are limited outcome data for PCI in this group. We evaluated the
outcome of PCI in patients aged  80 yrs and compared them with younger patients
treated in our centre.
Methods: We analysed all patients aged  80 yrs who underwent PCI in our unit
between Sept 2009 and Dec 2010. We defined major bleeding as the need for at-least one
unit of red cell transfusion.
Results: Of the 2931 patients who underwent PCI in our unit during the study period, 401
(13.7%) patients were80 yrs of age. Of these, 163 (40.6%) had primary PCI (PPCI) for
STEMI, 120 (29.9%) had PCI for non ST elevation ACS (NSTEACS) and 118 (29.4%)
had PCI for stable angina. The demographic, procedural data and mortality of octoge-
narians are compared with younger patients (Table 1). The total 30-day mortality for
patients aged  80 yrs was 8.7% compared with 1.3% for those aged 80 yrs
(P0.0001). This highly significant mortality difference was almost entirely to a fivefold
higher mortality in patients aged  80 yrs (20.2%) undergoing primary PCI (PPCI) for
STEMI compared with younger patients (3.9%). (Table 1) In Octogenarians, non fatal MI,
non fatal CVA and major bleeding occurred in 1.5%, 0.5% and 3.2% of all PCI patients,
2.5%, 0.6% and 3.1% of PPCI patients, 1.7%, 0% and 5% of patients undergoing PCI for
NSTE-ACS, 0%, 0.85% and 0.85% of patients undergoing PCI for stable angina
respectively.
n (%)
> 80 yrs
n401
<80 yrs
n 2530 p value
Age (meanSD) 84 4 63 10.2 0.0001
Male 225 (56.1) 1917 (75.8) 0.0001
PPCI for STEMI 163 (40.6) 765 (30.2) 0.0001
PCI for NSTE-ACS 120 (29.9) 739 (29.2) 0.77
PCI for stable angina 118 (29.4) 1026 (40.6) 0.0001
Diabetes 70 (17.5) 402 (15.9) 0.38
Cardiogenic shock 15 (3.7) 54 (2.1) 0.07
Previous MI 135 (33.7) 599 (23.7) 0.0001
Previous CABG 33 (8.2) 158 (6.2) 0.13
Previous PCI 55 (13.7) 488 (19.3) 0.007
No of stents (meanSD) 1.55 1.1 1.45 0.9 0.05
LMS involvement (75%
stenosis)
14 (3.5) 44 (1.7) 0.03
Single vessel PCI 303 (75.6) 2073 (81.9) 0.003
DES usage (at least 1 DES) 196 (48.9) 1667 (65.9) 0.0001
In-hospital mortality 25 (6.2) 24 (0.9) 0.0001
Total 30-day mortality 35 (8.7) 34 (1.3) 0.0001
30-day mortality in PPCI 33 (20.2) 30 (3.9) 0.0001
30-day mortality in NSTE-ACS 2 (1.7) 3 (0.4) 0.15
30-day mortality in Stable
angina
0 1 (0.1) 1
Conclusions: In this consecutive series from a high volume tertiary centre,
patients aged  80 yrs undergoing PCI have 30-day mortality rates similar to
younger patients treated for stable angina or NSTEACS. Further studies are
required to refine treatment strategies in unselected patients aged  80 yrs
undergoing PPCI for STEMI.
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Background: A few studies suggest a difference in management of ST elevation
Myocardial Infarction (STEMI) by gender. We will evaluated this point and the
implications from a prospective registry of 5000 patients.
Methods: We analyzed data collected in a 6 years period in the “Observatoire
Régional Breton sur l’Infarctus (ORBI)”, a prospective registry of STEMI patients
admitted within 24 h of symptom onset to an interventional cardiology centre in
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